MAPT and Alzheimer disease: Recently, there was an increased interest in the involvement of cell nuclear changes in Alzheimer's disease (AD) as most of its key players have been shown to be involved either in gene expression, e.g., ApoE4 [1], or in DNA alterations, e.g., the Tau protein [2].